Journal
CHEMICAL COMMUNICATIONS
Volume 56, Issue 44, Pages 5885-5888Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c9cc09883f
Keywords
-
Categories
Funding
- University of Zurich
- Swiss National Science Foundation through NCCR Kidney
- [205321_153523]
Ask authors/readers for more resources
A contrast agent for X-ray micro computed tomography (mu CT), called XlinCA, that combines reliable perfusion and permanent retention and contrast properties, was developed for ex vivo imaging. The new imaging agent XlinCA features high molecular weight, low viscosity and a high iodine content.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available